logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 10
  • 1
    Flanagan, Patrick
    Ceo born in February 1970
    Individual (6 offsprings)
    Officer
    2019-12-31 ~ now
    OF - Director → CIF 0
  • 2
    Henderson, Cynthia
    Executive Vice President born in February 1968
    Individual (6 offsprings)
    Officer
    2021-10-29 ~ now
    OF - Director → CIF 0
    Henderson, Cynthia
    Individual (6 offsprings)
    Officer
    2021-10-29 ~ now
    OF - Secretary → CIF 0
  • 3
    Halden, Kelvin
    Individual (1 offspring)
    Officer
    2010-02-12 ~ 2019-12-31
    OF - Secretary → CIF 0
  • 4
    Campbell, Kerri Clare
    Managing Director born in April 1971
    Individual (3 offsprings)
    Officer
    2002-02-13 ~ 2019-12-31
    OF - Director → CIF 0
    Mrs Kerri Clare Campbell
    Born in April 1971
    Individual (3 offsprings)
    Person with significant control
    2016-04-06 ~ 2019-12-31
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 5
    Campbell, Ewan James
    Scientist born in February 1964
    Individual (8 offsprings)
    Officer
    2006-04-01 ~ 2019-12-31
    OF - Director → CIF 0
    Mr Ewan James Campbell
    Born in February 1964
    Individual (8 offsprings)
    Person with significant control
    2016-04-06 ~ 2019-12-31
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 6
    Moulson, Richard
    Director born in April 1961
    Individual (3 offsprings)
    Officer
    2017-02-08 ~ 2019-12-31
    OF - Director → CIF 0
  • 7
    Cash, Kenneth Jason
    Cfo born in May 1978
    Individual (6 offsprings)
    Officer
    2019-12-31 ~ 2021-10-29
    OF - Director → CIF 0
    Cash, Kenneth Jason
    Individual (6 offsprings)
    Officer
    2019-12-31 ~ 2021-10-29
    OF - Secretary → CIF 0
  • 8
    VERISTAT INTERNATIONAL LIMITED
    10076882
    27, Old Gloucester Street, London, England
    Active Corporate (9 parents, 4 offsprings)
    Person with significant control
    2019-12-31 ~ dissolved
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 9
    BUSINESSLEGAL LTD - now 02970617
    M.J.F. (SERVICES) LIMITED - 2000-07-04
    9 Holgrave Close, High Legh, Knutsford, Cheshire
    Active Corporate (5 parents, 456 offsprings)
    Officer
    2002-02-12 ~ 2002-02-14
    OF - Nominee Director → CIF 0
  • 10
    BUSINESSLEGAL SECRETARIES LTD - now 03941113
    RAMPANT DRAGON PUBLIC HOUSE LIMITED - 2001-01-30
    9 Holgrave Close, High Legh, Knutsford, Cheshire
    Active Corporate (3 parents, 447 offsprings)
    Officer
    2002-02-12 ~ 2010-02-12
    OF - Nominee Secretary → CIF 0
parent relation
Company in focus

THE CLINICAL TRIAL COMPANY LTD

Period: 2002-02-12 ~ 2024-12-17
Company number: 04372093
Registered name
THE CLINICAL TRIAL COMPANY LTD - Dissolved
Standard Industrial Classification
86900 - Other Human Health Activities
74909 - Other Professional, Scientific And Technical Activities N.e.c.
72110 - Research And Experimental Development On Biotechnology
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Property, Plant & Equipment
64,081 GBP2018-03-31
43,901 GBP2017-03-31
Fixed Assets - Investments
17 GBP2018-03-31
17 GBP2017-03-31
Fixed Assets
64,098 GBP2018-03-31
43,918 GBP2017-03-31
Debtors
Current
950,804 GBP2018-03-31
584,732 GBP2017-03-31
Cash at bank and in hand
609,652 GBP2018-03-31
223,390 GBP2017-03-31
Current Assets
1,560,456 GBP2018-03-31
808,122 GBP2017-03-31
Net Current Assets/Liabilities
364,803 GBP2018-03-31
325,598 GBP2017-03-31
Total Assets Less Current Liabilities
428,901 GBP2018-03-31
369,516 GBP2017-03-31
Creditors
Non-current
-10,067 GBP2018-03-31
Net Assets/Liabilities
407,004 GBP2018-03-31
361,179 GBP2017-03-31
Equity
Called up share capital
9,500 GBP2018-03-31
9,500 GBP2017-03-31
Retained earnings (accumulated losses)
397,504 GBP2018-03-31
351,679 GBP2017-03-31
Equity
407,004 GBP2018-03-31
361,179 GBP2017-03-31
Property, Plant & Equipment - Gross Cost
Other
257,159 GBP2018-03-31
211,621 GBP2017-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
193,078 GBP2018-03-31
167,720 GBP2017-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
25,358 GBP2017-04-01 ~ 2018-03-31
Property, Plant & Equipment
Other
64,081 GBP2018-03-31
43,901 GBP2017-03-31
Trade Debtors/Trade Receivables
584,859 GBP2018-03-31
52,588 GBP2017-03-31
Amount of corporation tax that is recoverable
30,753 GBP2018-03-31
30,753 GBP2017-03-31
Amounts Owed By Related Parties
289,694 GBP2018-03-31
324,563 GBP2017-03-31
Other Debtors
45,498 GBP2018-03-31
176,828 GBP2017-03-31
Debtors
950,804 GBP2018-03-31
584,732 GBP2017-03-31
Finance Lease Liabilities - Total Present Value
Current
10,067 GBP2018-03-31
14,706 GBP2017-03-31
Trade Creditors/Trade Payables
Current
240,125 GBP2018-03-31
84,132 GBP2017-03-31
Corporation Tax Payable
Current
50,610 GBP2018-03-31
22,612 GBP2017-03-31
Other Taxation & Social Security Payable
Current
146,153 GBP2018-03-31
35,371 GBP2017-03-31
Other Creditors
Current
6,119 GBP2018-03-31
416 GBP2017-03-31
Accrued Liabilities/Deferred Income
Current
742,579 GBP2018-03-31
325,287 GBP2017-03-31
Finance Lease Liabilities - Total Present Value
Non-current
10,067 GBP2018-03-31
Minimum gross finance lease payments owing
Amounts falling due within one year
10,067 GBP2018-03-31
14,706 GBP2017-03-31
Minimum gross finance lease payments owing
20,134 GBP2018-03-31
14,706 GBP2017-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
47,500 shares2018-03-31
Par Value of Share
Class 1 ordinary share
10 GBP2017-04-01 ~ 2018-03-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
47,500 shares2018-03-31
Par Value of Share
Class 2 ordinary share
10 GBP2017-04-01 ~ 2018-03-31
Equity
Called up share capital
9,500 GBP2018-03-31
9,500 GBP2017-03-31
  • THE CLINICAL TRIAL COMPANY LTD
    Info
    Registered number 04372093
    27 Old Gloucester Street, London WC1N 3AX
    PRIVATE LIMITED COMPANY incorporated on 2002-02-12 and dissolved on 2024-12-17 (22 years 10 months). The status of the company number is Dissolved.
    The last date of confirmation statement was made at 2024-02-12
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 March 2026 and licensed under the Open Government Licence v3.0.